In addition, MGMT promoter unmethylation type shows a significantly higher expression of PTRF, indicating that higher PTRF expression is closely related to glioma ﻿temozolomide (TMZ) therapy resistance (p ≤ 6e-4, Fig. 1E). The gene discussed is CAVIN1; the disease is central nervous system cancer.